Arkolith/Insider Trading/ETON/Form 4

Opaleye Management Inc.

10% OwnerEton Pharmaceuticals, Inc. (ETON) · full profile →Form 4 · filed Oct 8, 2024
Net Buying
Open-Market Buys
$434K
Open-Market Sells
$0
Net Open-Market Flow
$434K
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 8, 2024Buy(P)4K$7.03$28K82K
Oct 8, 2024Buy(P)30K$7.03$211K2.8M
Oct 7, 2024Buy(P)1K$7.22$9K78K
Oct 7, 2024Buy(P)10K$7.22$72K2.7M
Oct 4, 2024Buy(P)2K$6.77$13K77K
Oct 4, 2024Buy(P)15K$6.77$102K2.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-040490) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML